Compare Incept Biosystems vs PTC Therapeutics
Customers evaluate the quality of Incept Biosystems's products using the following success metrics.
Overview
Incept Biosystems is 19 yrs old and is based in United States.
Incept BioSystems aims to develop nanoscale technologies that provide cell biologists the ability to obtain high value data about cell growth and behavior. Their technologies were developed to improve the in vitro manipulation, performance and viability for Premium Cell Management applications. On January 12, 2011, Incept BioSystems was acquired by ORIGIO. The terms of the transaction were not disclosed.
PTC Therapeutics is 26 yrs old and is based in United States.
PTC Therapeutics (NASDAQ: PTCT) is a global biopharmaceutical company. It focuses on the development of transformative therapies for rare diseases. The company's main offerings include the creation of new therapies that address the underlying cause of the disease, with a particular focus on modulating gene and protein expression. It serves the healthcare sector, particularly in areas related to rare and serious diseases. It was founded in 1998 and is based in South Plainfield, New Jersey.
Demo Video
Leadership
Christopher A Bleck (Chief Executive Officer)
Robert J. Schneider (Founder)
Investors
ORIGIO, Grand Angels
Blackstone, Delphi Ventures
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Incept Biosystems has not claimed their profile.
Work for Incept Biosystems? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Incept Biosystems?
Claim your profile now.
Information not available because PTC Therapeutics has not claimed their profile.
Work for PTC Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for PTC Therapeutics?
Claim your profile now.